nfl-101
Botanicalexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2020 (NCT04571216)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
Unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06091826 | Phase 2 | Feb 21, 2023 | Eurofins, NFL Biosciences SAS |
| NCT04571216 | Phase 2 | Jan 1, 2020 | Eurofins, NFL Biosciences SAS |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Eurofins | For profit | 2 | 0 | 1 | 2020 |
| NFL Biosciences SAS | For profit | 2 | 2 | 1 | 2020 |
2 organizations
Page 1 / 1